PROTECTIVE EFFECT OF SEROTONIN (5-HT(2)) RECEPTOR ANTAGONISTS IN ISCHEMIC RAT HEARTS

被引:21
作者
GROVER, GJ
SARGENT, CA
DZWONCZYK, S
NORMANDIN, DE
ANTONACCIO, MJ
机构
[1] Department of Pharmacology, The Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ
关键词
MYOCARDIAL ISCHEMIA; SEROTONIN; CINANSERIN; KETANSERIN; LY-53857; CONTRACTILE FUNCTION; REPERFUSION;
D O I
10.1097/00005344-199310000-00022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Serotonin (5-HT) may play a role in exacerbating thrombosis and coronary spasm during myocardial ischemia, but its role in mediating myocardial damage directly is not clear. We determined the effect of the 5-HT2 receptor antagonists cinanserin (0.1-10 muM), ketanserin (0.3-10 muM), and LY 53857 (1-10 muM) on time to contracture, recovery of contractile function, and lactate dehydrogenase (LDH) release after 25-min global ischemia and 30-min reperfusion in isolated rat heart. All 5-HT2 antagonists significantly increased time to contracture in a concentration-dependent manner (EC25 = 1.6, 5.5, and 6.1 muM for cinansefin, ketanserin, and LY 53857, respectively). These compounds also significantly reduced LDH release and improved recovery of contractile function during reperfusion. 5-HT greater-than-or-equal-to 30 muM significantly reduced time to contracture, indicating a proischemic effect. The proischemic effect of 5-HT was abolished by ketanserin and cinansefin. Inhibition of 5-HT synthesis by parachlorophenylalanine resulted in significant cardio-protection, further indicating the involvement of 5-HT in the pathogenesis of ischemia in this model. Although cinansefin and ketanserin had alpha1-adrenoceptor blocking effects, LY 53857 was devoid of this activity at concentrations exhibiting cardioprotection. Therefore, 5-HT may exacerbate ischemic injury in rat heart, and this exacerbation appears to be mediated specifically by 5-HT, receptors.
引用
收藏
页码:664 / 672
页数:9
相关论文
共 29 条
[1]   SEROTONIN-S2 AND THROMBOXANE-A2-PROSTAGLANDIN-H2 RECEPTOR BLOCKADE PROVIDE PROTECTION AGAINST EPINEPHRINE-INDUCED CYCLIC FLOW VARIATIONS IN SEVERELY NARROWED CANINE CORONARY-ARTERIES [J].
ASHTON, JH ;
GOLINO, P ;
MCNATT, JM ;
BUJA, LM ;
WILLERSON, JT .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (03) :755-763
[2]   CORRELATION OF PLASMA SEROTONIN CHANGES WITH PLATELET-AGGREGATION IN AN INVIVO DOG-MODEL OF SPONTANEOUS OCCLUSIVE CORONARY THROMBUS FORMATION [J].
BENEDICT, CR ;
MATHEW, B ;
REX, KA ;
CARTWRIGHT, J ;
SORDAHL, LA .
CIRCULATION RESEARCH, 1986, 58 (01) :58-67
[3]   DISPOSITION OF SEROTONIN IN RAT BLOOD-VESSELS AND HEART [J].
BERKOWITZ, BA ;
LEE, CH ;
SPECTOR, S .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1974, 1 (05) :397-400
[4]   PARACHLOROPHENYLALANINE AND COPULATORY-BEHAVIOR IN NEONATALLY CASTRATED MALE-RATS [J].
BOOTH, JE ;
VANDERSCHOOT, P ;
MOLEMAN, P .
PHYSIOLOGY & BEHAVIOR, 1979, 23 (04) :701-707
[5]  
BUSH LR, 1987, J PHARMACOL EXP THER, V240, P674
[6]  
COHEN ML, 1988, J CARDIOVASC PHARM, V11, pS25
[7]  
COHEN ML, 1983, J PHARMACOL EXP THER, V227, P327
[8]   SEROTONIN RECEPTORS - THERAPEUTIC PROSPECTS IN CARDIOVASCULAR-DISEASE [J].
CONNOR, HE ;
HUMPHREY, PPA ;
FENIUK, W .
TRENDS IN CARDIOVASCULAR MEDICINE, 1991, 1 (05) :205-210
[9]   DOI IS A MIXED AGONIST-ANTAGONIST AT POSTJUNCTIONAL 5-HT2 RECEPTORS IN THE PITHED RAT [J].
DABIRE, H ;
CHAOUCHETEYARA, K ;
CHERQUI, C ;
FOURNIER, B ;
SCHMITT, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 170 (1-2) :109-111
[10]   PROTECTIVE EFFECT OF A PROSTACYCLIN-MIMETIC ON THE ISCHEMIC REPERFUSED RABBIT MYOCARDIUM [J].
FERRARI, R ;
CARGNONI, A ;
CECONI, C ;
CURELLO, S ;
BELLOLI, S ;
ALBERTINI, A ;
VISIOLI, O .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1988, 20 (12) :1095-1106